Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05824091 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults
A Phase 1 study, sponsored by Gates Medical Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 119
- Enrollment target
NCT05824091 is a Phase 1 study that has completed, run by Gates Medical Research Institute. The registered enrollment target is 119 participants.
The verdict
NCT05824091, a Phase 1 study, has completed, sponsored by Gates Medical Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 119 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of single and then multiple doses of MK-7762 (TBD09) in healthy volunteers in the context of a first-in-human study. The effect of food on the rate and extent of absorption of a single oral dose of MK-7762 (TBD09) will also be evaluated.
Interventions
- OTHER Placebo
- DRUG MK-7762 (TBD09)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2023-02-23 |
| Est. Completion | 2024-03-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05824091
The ClinicalTrials.gov registry entry for NCT05824091 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gates Medical Research Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05824091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05824091 about?
NCT05824091 is a clinical study titled "Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults". The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of single and then multiple doses of MK-7762 (TBD09) in healthy volunteers in the context of a first-in-human study. The effect of food on the rate and extent of absorption of a single oral dose of MK-7762 (T...
What is the current status of trial NCT05824091?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 119 participants. The study started on 2023-02-23. Estimated completion is 2024-03-26.
What interventions are being tested in trial NCT05824091?
The interventions under investigation include: Placebo (OTHER), MK-7762 (TBD09) (DRUG).
Who is sponsoring clinical trial NCT05824091?
This trial is sponsored by Gates Medical Research Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.